Igor A. Sherman
Algemeen Directeur bij Alpha Cancer Technologies, Inc.
Actieve functies van Igor A. Sherman
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Alpha Cancer Technologies, Inc.
Alpha Cancer Technologies, Inc. Pharmaceuticals: MajorHealth Technology Alpha Cancer Technologies, Inc. develops oncology and auto-immune disease treatments. Its products include Alpha Fetoprotein, immunotherapy and targeted chemotherapy platform. The company was founded by Igor A. Sherman in 2008 and is headquartered in Toronto, Canada. | Algemeen Directeur | 01-01-2008 | - |
Oprichter | 01-01-2008 | - | |
President | 01-01-2008 | - |
Loopbaan van Igor A. Sherman
Eerdere bekende functies van Igor A. Sherman
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
JPMorgan Securities LLC
JPMorgan Securities LLC Investment ManagersFinance JPMorgan Securities LLC (JPMS) is a securities brokerage firm headquartered in New York City. The firm was founded in 1985 and is a subsidiary of JPMorgan Broker-Dealer Holdings, Inc., ultimately held by JPMorgan Chase & Co., Inc. (NYSE: JPM). JPMS provides research on fixed income, credit, derivatives, emerging markets, foreign exchange, structured finance, technical analysis and bond indices. Their equity analysts cover equities throughout North America, EMEA, Asia/Pacific and the emerging markets. The firm's fixed income team formulates trading and portfolio recommendations for investors in global bonds and other fixed-income markets based on valuations, analytics and market dynamics. | Analist-Vaste Inkomen | 01-01-2005 | 01-08-2010 |
YM BioSciences, Inc.
YM BioSciences, Inc. Pharmaceuticals: MajorHealth Technology YM BioSciences, Inc. operates as a drug development company, which manufactures advancing hematology and cancer-related products. It is currently advancing in late-stage products, which include CYT387, an oral small molecule inhibitor of the kinase enzymes JAK1 and JAK2; and Nimotuzumab, an EGFR targeting humanized monoclonal antibody. The company was founded in 1994 and is headquartered in Mississauga, Canada. | Hoofd Techniek/Wetenschap/O&O | - | - |
Opleiding van Igor A. Sherman
University of Connecticut | Undergraduate Degree |
Statistieken
Internationaal
Canada | 3 |
Verenigde Staten | 3 |
Operationeel
Analyst-Fixed Income | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Undergraduate Degree | 1 |
Sectoraal
Health Technology | 3 |
Finance | 2 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 3 |
---|---|
YM BioSciences, Inc.
YM BioSciences, Inc. Pharmaceuticals: MajorHealth Technology YM BioSciences, Inc. operates as a drug development company, which manufactures advancing hematology and cancer-related products. It is currently advancing in late-stage products, which include CYT387, an oral small molecule inhibitor of the kinase enzymes JAK1 and JAK2; and Nimotuzumab, an EGFR targeting humanized monoclonal antibody. The company was founded in 1994 and is headquartered in Mississauga, Canada. | Health Technology |
JPMorgan Securities LLC
JPMorgan Securities LLC Investment ManagersFinance JPMorgan Securities LLC (JPMS) is a securities brokerage firm headquartered in New York City. The firm was founded in 1985 and is a subsidiary of JPMorgan Broker-Dealer Holdings, Inc., ultimately held by JPMorgan Chase & Co., Inc. (NYSE: JPM). JPMS provides research on fixed income, credit, derivatives, emerging markets, foreign exchange, structured finance, technical analysis and bond indices. Their equity analysts cover equities throughout North America, EMEA, Asia/Pacific and the emerging markets. The firm's fixed income team formulates trading and portfolio recommendations for investors in global bonds and other fixed-income markets based on valuations, analytics and market dynamics. | Finance |
Alpha Cancer Technologies, Inc.
Alpha Cancer Technologies, Inc. Pharmaceuticals: MajorHealth Technology Alpha Cancer Technologies, Inc. develops oncology and auto-immune disease treatments. Its products include Alpha Fetoprotein, immunotherapy and targeted chemotherapy platform. The company was founded by Igor A. Sherman in 2008 and is headquartered in Toronto, Canada. | Health Technology |
- Beurs
- Insiders
- Igor A. Sherman
- Ervaring